TFX logo

Teleflex Incorporated Stock Price

NYSE:TFX Community·US$5.6b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 13 Fair Values set on narratives written by author

TFX Share Price Performance

US$126.88
-53.26 (-29.57%)
US$124.14
Fair Value
US$126.88
-53.26 (-29.57%)
2.2% overvalued intrinsic discount
US$124.14
Fair Value
Price US$126.88
AnalystConsensusTarget US$124.14
AnalystLowTarget US$120.00
AnalystHighTarget US$200.00

TFX Community Narratives

AnalystConsensusTarget·
Fair Value US$124.14 2.2% overvalued intrinsic discount

Acquisitions And Asian Expansion Will Broaden Healthcare Horizons

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AnalystLowTarget·
Fair Value US$120 5.7% overvalued intrinsic discount

Rising Cost Pressures And Supply Risks Will Shrink Healthcare Prospects

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AnalystHighTarget·
Fair Value US$152.8 17.0% undervalued intrinsic discount

Aging Populations And Emerging Markets Will Transform Medical Devices

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
US$120
5.7% overvalued intrinsic discount
Revenue
6.09% p.a.
Profit Margin
10.58%
Future PE
14.32x
Price in 2028
US$150.87

Trending Discussion

Updated Narratives

TFX logo

TFX: Diabetes Trial And Goodwill Charge Will Shape Balanced Future Outlook

Fair Value: US$124.14 2.2% overvalued intrinsic discount
7 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TFX logo

Rising Cost Pressures And Supply Risks Will Shrink Healthcare Prospects

Fair Value: US$120 5.7% overvalued intrinsic discount
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TFX logo

Aging Populations And Emerging Markets Will Transform Medical Devices

Fair Value: US$152.8 17.0% undervalued intrinsic discount
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Fair value with moderate growth potential.

1 Risk
2 Rewards

Teleflex Incorporated Key Details

US$3.2b

Revenue

US$1.5b

Cost of Revenue

US$1.7b

Gross Profit

US$2.1b

Other Expenses

-US$327.9m

Earnings

Last Reported Earnings
Sep 28, 2025
Next Reporting Earnings
n/a
-7.42
54.02%
-10.28%
73.1%
View Full Analysis

About TFX

Founded
1943
Employees
14100
CEO
Liam Kelly
WebsiteView website
www.teleflex.com

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various coronary catheters, structural heart support devices, peripheral intervention products, and mechanical circulatory support platform; and Arrow branded intra-aortic balloon pumps and catheters, Guideliner, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway, pain management, and hemostatic products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligating clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology, as well as bladder management services; and OEM products, which includes the TFX Medical OEM, TFX OEM, Deknatel, and HPC Medical brands. It serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Recent TFX News & Updates

Recent updates

No updates